Summary
Cardinal Health Inc. (CAH) reported revenues of $18.6 billion for the three months ended December 31, 2004, a 13% increase year-over-year. However, the company experienced a significant 45% decline in operating earnings for the same period, reaching $320.8 million, largely due to substantial special items including restructuring costs and impairment charges, which totaled $103.1 million. The company is also undergoing various investigations by the SEC and U.S. Attorney's Office, leading to restatements of prior financial periods and disciplinary actions. Despite these challenges, the company continues to execute a global restructuring program aimed at improving efficiency and future profitability, with projected savings of $125 million in fiscal year 2005.
Key Highlights
- 1Revenue increased by 13% to $18.6 billion for the three months ended December 31, 2004, compared to the prior year.
- 2Operating earnings decreased by 45% to $320.8 million for the three months ended December 31, 2004, compared to the prior year, primarily impacted by special items.
- 3The company incurred $103.1 million in special items during the quarter, including restructuring costs and merger-related expenses, partially offset by litigation settlements.
- 4Significant asset impairments totaling $83.0 million were recorded during the quarter, impacting the Pharmaceutical Technologies and Services segment.
- 5Cardinal Health is subject to ongoing investigations by the SEC and U.S. Attorney's Office, leading to prior period financial statement restatements.
- 6A global restructuring program is underway, with Phase I expected to rationalize facilities and workforce, aiming for significant cost savings.
- 7The company's Pharmaceutical Distribution business is transitioning to a fee-for-service model to address declining vendor margins.